Based on the observation that managers provide almost 30% more revenue than earnings forecasts in recent periods, we jointly explore the decision to provide or forego revenue and/or earnings guidance. Our modeling innovation combines a random effects multinomial logit model, instrumental...

We examine the effect of the Jumpstart Our Business Startups (JOBS) Act on biotech startups, who conduct almost 40% of IPOs since 2012. Reduced compliance costs encourage innovation capital formation as biotech IPO volume increases 200% and proceeds rise by 30%. After the JOBS Act, biotech...